NOT KNOWN FACTS ABOUT SEMAGLUTUDE WEEKS 13-16 BUNDLE

Thyroid C-mobile Tumors: In rodent reports, semaglutide continues to be demonstrated to trigger thyroid C-cell tumors. It's not known irrespective of whether this threat applies to humans, but semaglutide is contraindicated in sufferers with a personal or family historical past of medullary thyroid carcinoma (MTC) or people with Several Endocrine N